The IRS will generally consider GLP-1 medications a qualified medical expense that's tax deductible if both of the following qualifications are true: A doctor or another medical provider diagnoses you with a disease, AND A GLP-1 medication like Wegovy or Ozempic is prescribed to treat that disease
Reference List American Diabetes Association
Two groups were matched for age, gender, comorbidities, and other soft tissue and inflammatory issues, HbA1c, sleep apne, BMI, opioid use, NSAID use, antidepressants
According to ADMs research, 83% of consumers taking AOMs find food products to be appealing when specifically marketed toward people on GLP-1 medications
Furthermore, Ozempics mechanism of action also includes slowing down gastric emptying, which contributes to prolonged feelings of fullness and a more gradual rise in blood sugar levels after eating
The short answer is no, Ozempic doesn't cause true withdrawal